systemic chemotherapy
DrugOther names: none noted
NCT Number: NCT00751816
RATIONALE: Early physical therapy may be effective in improving range of motion of the neck and shoulders in head and neck cancer survivors who are undergoing chemotherapy and radiation therapy.
PURPOSE: This phase I trial is studying how well early physical therapy works in improving physical and functional well-being in head and neck cancer survivors receiving chemoradiotherapy.
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
OBJECTIVES:
OUTLINE: Patients undergo physical therapy weekly for 10 weeks beginning 1 week prior to initiating adjuvant chemoradiotherapy and continuing until 2 weeks after the completion of adjuvant chemoradiotherapy.
Patients undergo range of motion assessment and complete a Cancer Survivorship Survey (CSS) at baseline and in weeks 4, 8, 9, and 10 of physical therapy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
DISEASE CHARACTERISTICS:
Exclusion criteria
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Other names: none noted
will be administered before, during, and after medical intent-to-cure treatment to describe head and neck cancer survivors' physical and functional well-being.
Other names: none noted
Other names: none noted
Other names: None noted
Other names: none noted
weekly visits coordinated with adjuvant treatment as part of standard care
Other names: none noted
Other names: none noted
Time frame: 2 weeks after completing treatment
Time frame: 2 weeks after completing treatment
Time frame: 2 weeks after completing treatment
Vanderbilt University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00984074
Carcinoma, Carcinoma, Squamous Cell
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00509665
Carcinoma, Carcinoma, Squamous Cell
Charleston, South Carolina, United States
View Trial DetailsNCT01156142
Carcinoma, Carcinoma, Squamous Cell
Scottsdale, Arizona, United States
View Trial DetailsNCT01015963
Bladder Cancer, Breast Cancer
View Trial Details